← HDFC Mutual Fund
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF179KC1HO1
NAV · 06-Jul-2026
₹21.3890
1M
+7.85%
6M
+20.13%
1Y (CAGR)
+23.30%
3Y (CAGR)
—
5Y (CAGR)
—
Since inception (CAGR)
+32.11%
NAV history
hover for values
Risk & SIP analytics
Volatility (3y)
14.22%
Downside dev (3y)
10.77%
Max drawdown (3y)
-14.9%
Calendar-year returns
2024 +52.2%2025 +2.4%
Fund facts
Fund managerDhruv Muchhal · Nikhil Mathur
AUM₹23,624 Cr
Expense ratio0.92% · 2026-05-31
TER · AMFI officialDirect 1.15% · Regular 2.23% (2026-06-30)
Launch date14-Sep-2023
Plan typeOpen Ended · Equity
Min lumpsum₹100
Min SIP₹100
Lock-inNone
Volatility14.20
AMCHDFC Asset Management Company Limited
Objective · To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
scheme documents ↗